Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers

We have compared the incidence of CNS symptoms and changes in echocardiography and electrophysiology during i.v. infusions of ropivacaine, bupivacaine and placebo. Acute tolerance of i.v. infusion of 10 mg min-1 was studied in a crossover, randomized, double-blind study in 12 volunteers previously a...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of anaesthesia : BJA Vol. 78; no. 5; pp. 507 - 514
Main Authors Knudsen, K, Beckman Suurküla, M, Blomberg, S, Sjövall, J, Edvardsson, N
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.05.1997
Oxford University Press
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We have compared the incidence of CNS symptoms and changes in echocardiography and electrophysiology during i.v. infusions of ropivacaine, bupivacaine and placebo. Acute tolerance of i.v. infusion of 10 mg min-1 was studied in a crossover, randomized, double-blind study in 12 volunteers previously acquainted with the CNS effects of lignocaine. The maximum tolerated dose for CNS symptoms was higher after ropivacaine in nine of 12 subjects and higher after bupivacaine in three subjects. The 95% confidence limits for the difference in mean dose between ropivacaine and bupivacaine were -30 and 7 mg. The maximum tolerated unbound arterial plasma concentration was twice as high after ropivacaine (P < 0.001). Muscular twitching occurred more frequently after bupivacaine (P < 0.05). The time to disappearance of all symptoms was shorter after ropivacaine (P < 0.05). A threshold for CNS toxicity was apparent at a mean free plasma concentration of approximately 0.6 mg litre-1 for ropivacaine and 0.3 mg litre-1 for bupivacaine. Bupivacaine increased QRS width during sinus rhythm compared with placebo (P < 0.001) and ropivacaine (P < 0.01). Bupivacaine reduced both left ventricular systolic and diastolic function compared with placebo (P < 0.05 and P < 0.01, respectively), while ropivacaine reduced only systolic function (P < 0.01).
AbstractList We have compared the incidence of CNS symptoms and changes in echocardiography and electrophysiology during i.v. infusions of ropivacaine, bupivacaine and placebo. Acute tolerance of i.v. infusion of 10 mg min-1 was studied in a crossover, randomized, double-blind study in 12 volunteers previously acquainted with the CNS effects of lignocaine. The maximum tolerated dose for CNS symptoms was higher after ropivacaine in nine of 12 subjects and higher after bupivacaine in three subjects. The 95% confidence limits for the difference in mean dose between ropivacaine and bupivacaine were -30 and 7 mg. The maximum tolerated unbound arterial plasma concentration was twice as high after ropivacaine (P < 0.001). Muscular twitching occurred more frequently after bupivacaine (P < 0.05). The time to disappearance of all symptoms was shorter after ropivacaine (P < 0.05). A threshold for CNS toxicity was apparent at a mean free plasma concentration of approximately 0.6 mg litre-1 for ropivacaine and 0.3 mg litre-1 for bupivacaine. Bupivacaine increased QRS width during sinus rhythm compared with placebo (P < 0.001) and ropivacaine (P < 0.01). Bupivacaine reduced both left ventricular systolic and diastolic function compared with placebo (P < 0.05 and P < 0.01, respectively), while ropivacaine reduced only systolic function (P < 0.01).
We have compared the incidence of CNS symptoms and changes in echocardiography and electrophysiology during i.v. infusions of ropivacaine, bupivacaine and placebo. Acute tolerance of i.v. infusion of 10 mg min-1 was studied in a crossover, randomized, double-blind study in 12 volunteers previously acquainted with the CNS effects of lignocaine. The maximum tolerated dose for CNS symptoms was higher after ropivacaine in nine of 12 subjects and higher after bupivacaine in three subjects. The 95% confidence limits for the difference in mean dose between ropivacaine and bupivacaine were -30 and 7 mg. The maximum tolerated unbound arterial plasma concentration was twice as high after ropivacaine (P < 0.001). Muscular twitching occurred more frequently after bupivacaine (P < 0.05). The time to disappearance of all symptoms was shorter after ropivacaine (P < 0.05). A threshold for CNS toxicity was apparent at a mean free plasma concentration of approximately 0.6 mg litre-1 for ropivacaine and 0.3 mg litre-1 for bupivacaine. Bupivacaine increased QRS width during sinus rhythm compared with placebo (P < 0.001) and ropivacaine (P < 0.01). Bupivacaine reduced both left ventricular systolic and diastolic function compared with placebo (P < 0.05 and P < 0.01, respectively), while ropivacaine reduced only systolic function (P < 0.01).We have compared the incidence of CNS symptoms and changes in echocardiography and electrophysiology during i.v. infusions of ropivacaine, bupivacaine and placebo. Acute tolerance of i.v. infusion of 10 mg min-1 was studied in a crossover, randomized, double-blind study in 12 volunteers previously acquainted with the CNS effects of lignocaine. The maximum tolerated dose for CNS symptoms was higher after ropivacaine in nine of 12 subjects and higher after bupivacaine in three subjects. The 95% confidence limits for the difference in mean dose between ropivacaine and bupivacaine were -30 and 7 mg. The maximum tolerated unbound arterial plasma concentration was twice as high after ropivacaine (P < 0.001). Muscular twitching occurred more frequently after bupivacaine (P < 0.05). The time to disappearance of all symptoms was shorter after ropivacaine (P < 0.05). A threshold for CNS toxicity was apparent at a mean free plasma concentration of approximately 0.6 mg litre-1 for ropivacaine and 0.3 mg litre-1 for bupivacaine. Bupivacaine increased QRS width during sinus rhythm compared with placebo (P < 0.001) and ropivacaine (P < 0.01). Bupivacaine reduced both left ventricular systolic and diastolic function compared with placebo (P < 0.05 and P < 0.01, respectively), while ropivacaine reduced only systolic function (P < 0.01).
Author Sjövall, J
Edvardsson, N
Knudsen, K
Beckman Suurküla, M
Blomberg, S
Author_xml – sequence: 1
  givenname: K
  surname: Knudsen
  fullname: Knudsen, K
– sequence: 2
  givenname: M
  surname: Beckman Suurküla
  fullname: Beckman Suurküla, M
– sequence: 3
  givenname: S
  surname: Blomberg
  fullname: Blomberg, S
– sequence: 4
  givenname: J
  surname: Sjövall
  fullname: Sjövall, J
– sequence: 5
  givenname: N
  surname: Edvardsson
  fullname: Edvardsson, N
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2681706$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/9175963$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1rFTEUxYO01Nfqzq0wiOimM01mXr6W8lBbKHSj65CPG8hjXjImMwP-98a-ZxdFcRWS-zuHm3Mu0VlMERB6Q3BHsBxuzF7fcNHRjmL-Am3IlpOWcU7O0AZjzFssSf8SXZayx5jwXtILdCEJp5ING5R3EOesxyZCXtNSGh1dY3V2Ia262GXUuQHvwc6lSb4J3do1IfqlhBQfX3KawqqtDhGuG7M8XR6NplFbMKkqmjWNS5wBcnmFzr0eC7w-nVfo-5fP33a37f3D17vdp_vWbgWfW4OdcJRxj4XwXPfCG-Gkw5gSK6RjnGrtrDWOe7klhoEDYcjAMZVGcmKHK_Th6Dvl9GOBMqtDKBbGUUeoP1VcYorpVlbw3TNwn5Yc626KSC7YIBip0NsTtJgDODXlcND5pzolWefvT_Mamx591tGG8oT1TBCOWcX6I2ZzKiWDVzbMeq5p1hbCqAhWv0tVtVTFhaKqllpF189Ef2z_gX884mmZ_keyIwm1hzVAVsUGiBZcyLVy5VL4u_AXZYLDwQ
CODEN BJANAD
CitedBy_id crossref_primary_10_1016_j_joms_2018_03_037
crossref_primary_10_1213_01_ANE_0000074649_01876_E7
crossref_primary_10_1016_j_jse_2020_10_012
crossref_primary_10_1097_00003643_200100001_00058
crossref_primary_10_1213_01_ANE_0000062524_90936_1F
crossref_primary_10_1248_bpb_28_2271
crossref_primary_10_1016_S1280_4703_18_41552_6
crossref_primary_10_1016_j_jclinane_2011_10_013
crossref_primary_10_1136_rapm_2025_106500
crossref_primary_10_1007_s00405_013_2859_4
crossref_primary_10_1097_00000539_200208000_00040
crossref_primary_10_1136_rapm_2019_100585
crossref_primary_10_1097_00000539_199809000_00025
crossref_primary_10_1186_s40981_015_0015_4
crossref_primary_10_1007_s11999_009_1198_7
crossref_primary_10_1093_bja_aen297
crossref_primary_10_1097_00000539_200211000_00046
crossref_primary_10_1308_003588410X12628812459733
crossref_primary_10_1097_00000539_200103001_00006
crossref_primary_10_3349_ymj_2007_48_2_331
crossref_primary_10_1016_S0007_1226_03_00180_2
crossref_primary_10_1111_j_1460_9592_2004_01550_x
crossref_primary_10_18410_jebmh_2017_662
crossref_primary_10_1007_BF03021035
crossref_primary_10_1007_s12663_021_01548_7
crossref_primary_10_1016_j_jos_2016_02_002
crossref_primary_10_1017_S0265021505241066
crossref_primary_10_1080_08941939_2017_1363325
crossref_primary_10_1186_s12871_019_0890_8
crossref_primary_10_4103_1658_354X_84101
crossref_primary_10_1002_jso_25280
crossref_primary_10_3390_pharmaceutics14040708
crossref_primary_10_1007_s10397_012_0761_5
crossref_primary_10_1093_bja_aef219
crossref_primary_10_1111_bjd_19551
crossref_primary_10_1186_s12871_020_01093_9
crossref_primary_10_1007_s40261_025_01419_w
crossref_primary_10_1016_j_ijporl_2008_01_029
crossref_primary_10_1097_00115550_200505000_00024
crossref_primary_10_1111_j_1365_2044_2007_05197_x
crossref_primary_10_2165_00128072_200204100_00003
crossref_primary_10_1016_j_jclinane_2024_111470
crossref_primary_10_14260_jemds_2016_266
crossref_primary_10_1007_s00540_014_1904_9
crossref_primary_10_1186_s12871_024_02590_x
crossref_primary_10_1007_s00228_010_0927_x
crossref_primary_10_1007_s11916_017_0604_1
crossref_primary_10_5005_jp_journals_10003_1409
crossref_primary_10_1016_j_bjps_2007_10_034
crossref_primary_10_1097_00000539_200105000_00034
crossref_primary_10_1053_bean_2002_0241
crossref_primary_10_2106_00004623_200602000_00005
crossref_primary_10_1177_0310057X231198255
crossref_primary_10_1016_j_jclinane_2024_111589
crossref_primary_10_1097_FTD_0b013e31802c59ec
crossref_primary_10_1097_FTD_0000000000000091
crossref_primary_10_1053_bean_2002_0237
crossref_primary_10_1016_j_clinthera_2015_03_017
crossref_primary_10_2165_00003495_200565060_00003
crossref_primary_10_1016_j_ajem_2022_06_017
crossref_primary_10_2460_ajvr_71_8_875
crossref_primary_10_3389_fmed_2022_834334
crossref_primary_10_1007_BF03021493
crossref_primary_10_2147_DDDT_S492040
crossref_primary_10_1046_j_1460_9592_2000_00454_x
crossref_primary_10_1007_s00266_017_0802_6
crossref_primary_10_3389_fmed_2022_857427
crossref_primary_10_1016_j_annfar_2014_07_021
crossref_primary_10_1097_00001503_200312000_00001
crossref_primary_10_1007_s12630_015_0564_z
crossref_primary_10_4103_2455_3069_184114
crossref_primary_10_1177_0363546511402780
crossref_primary_10_1007_s11419_024_00695_z
crossref_primary_10_1034_j_1399_6576_2002_460607_x
crossref_primary_10_1097_00115550_200309000_00007
crossref_primary_10_1016_j_bjps_2007_09_042
crossref_primary_10_1097_00115550_200603000_00021
crossref_primary_10_5005_jp_journals_10033_1349
crossref_primary_10_1097_MD_0000000000021126
crossref_primary_10_1016_j_spinee_2013_06_041
crossref_primary_10_1016_j_lpm_2012_04_016
crossref_primary_10_1213_ANE_0000000000004219
crossref_primary_10_1016_j_bja_2020_01_026
crossref_primary_10_1016_j_arth_2006_09_004
crossref_primary_10_1016_j_rcot_2017_10_011
crossref_primary_10_1136_rapm_2018_000016
crossref_primary_10_1016_j_jopan_2024_05_012
crossref_primary_10_4097_kjae_2012_62_1_52
crossref_primary_10_1111_j_0001_6349_2004_00344_x
crossref_primary_10_4103_njms_njms_100_22
crossref_primary_10_1046_j_1365_2044_1999_00668_x
crossref_primary_10_1016_j_ejps_2007_09_010
crossref_primary_10_1155_2017_4260702
crossref_primary_10_1186_s43019_024_00211_y
crossref_primary_10_1213_ANE_0b013e3182a1af78
crossref_primary_10_1213_00000539_199907000_00019
crossref_primary_10_1097_00000539_200008000_00032
crossref_primary_10_14260_jemds_2016_1448
crossref_primary_10_1007_s12325_018_0836_4
crossref_primary_10_1097_00115550_200201000_00007
crossref_primary_10_1111_j_1460_9592_2004_01364_x
crossref_primary_10_1007_s10286_023_00953_x
crossref_primary_10_1016_S0003_4975_02_03710_4
crossref_primary_10_1177_09603271211065978
crossref_primary_10_1016_j_ijoa_2005_01_002
crossref_primary_10_5812_ijcm_98879
crossref_primary_10_1016_j_jse_2006_04_015
crossref_primary_10_1111_j_1600_0722_2006_00272_x
crossref_primary_10_1007_s11419_021_00574_x
crossref_primary_10_1053_j_jvca_2006_02_032
crossref_primary_10_1111_j_1460_9592_2011_03730_x
crossref_primary_10_1093_bja_aen137
crossref_primary_10_1097_EJA_0b013e328350b0d5
crossref_primary_10_1590_S0034_70942009000300002
crossref_primary_10_1097_EJA_0000000000000198
crossref_primary_10_1007_s00228_002_0540_8
crossref_primary_10_1007_BF03020490
crossref_primary_10_1007_s00101_008_1303_4
crossref_primary_10_1016_S0163_7258_99_00034_0
crossref_primary_10_1080_17453670710013663
crossref_primary_10_1097_01_aco_0000182564_25057_fa
crossref_primary_10_1111_j_1368_5031_2004_00114_x
crossref_primary_10_3390_jcm12041541
crossref_primary_10_1016_j_jclinane_2024_111430
crossref_primary_10_1016_j_ijoa_2007_05_015
crossref_primary_10_1054_ijoa_2000_0783
crossref_primary_10_1017_S0265021505002218
crossref_primary_10_1097_ANA_0000000000000422
crossref_primary_10_1111_pan_14170
crossref_primary_10_1007_BF03020376
crossref_primary_10_1067_moe_2001_114000
crossref_primary_10_1136_rapm_2021_103427
crossref_primary_10_3747_pdi_2017_00222
crossref_primary_10_4097_kjae_2010_59_1_27
crossref_primary_10_1007_s00068_024_02597_6
crossref_primary_10_1213_00000539_200208000_00040
crossref_primary_10_1213_00000539_199809000_00025
crossref_primary_10_2106_JBJS_E_00173
crossref_primary_10_1097_ANA_0000000000000408
crossref_primary_10_1016_j_annfar_2004_03_012
crossref_primary_10_1111_j_1460_9592_2006_01841_x
crossref_primary_10_1007_s40140_020_00381_x
crossref_primary_10_1111_bcpt_12644
crossref_primary_10_1007_BF03061671
crossref_primary_10_1111_bcp_12582
crossref_primary_10_1159_000363233
crossref_primary_10_1177_0363546512439025
crossref_primary_10_1007_s00228_011_1139_8
crossref_primary_10_25284_2519_2078_1_98__2022_256099
crossref_primary_10_1016_j_anclin_2025_02_002
crossref_primary_10_1001_jamasurg_2022_2814
crossref_primary_10_1007_BF03019374
crossref_primary_10_1097_01_bpo_0000235392_26666_6b
crossref_primary_10_1097_01_aia_0000166191_98814_59
crossref_primary_10_1016_S0886_3350_02_01268_3
crossref_primary_10_1016_j_jmig_2008_05_012
crossref_primary_10_1016_j_ijom_2009_11_009
crossref_primary_10_1016_j_bjan_2018_01_004
crossref_primary_10_1016_j_wneu_2024_03_072
crossref_primary_10_14260_jemds_2014_2220
crossref_primary_10_1017_S0265021507002542
crossref_primary_10_1016_S0031_3955_05_70225_X
crossref_primary_10_1097_00000539_200112000_00057
crossref_primary_10_1177_1120672120969370
crossref_primary_10_1017_S0265021505280535
crossref_primary_10_1213_01_ane_0000278129_37099_fa
crossref_primary_10_1046_j_1365_2044_2002_02621_x
crossref_primary_10_1111_fcp_12836
crossref_primary_10_1007_s00590_013_1231_0
crossref_primary_10_1213_01_ane_0000281434_80883_88
crossref_primary_10_14260_jemds_2016_130
crossref_primary_10_1016_j_cvex_2021_08_015
crossref_primary_10_1007_s10867_008_9094_z
crossref_primary_10_1097_00115550_200001000_00009
crossref_primary_10_2147_JPR_S343366
crossref_primary_10_1097_00115550_200411000_00009
crossref_primary_10_1155_2012_962101
crossref_primary_10_1016_S0889_8537_02_00032_9
crossref_primary_10_1186_s40981_017_0077_6
crossref_primary_10_1016_j_sjpain_2011_09_001
crossref_primary_10_1097_AAP_0b013e318281a348
crossref_primary_10_3389_fmolb_2023_1243103
crossref_primary_10_1097_00000539_199907000_00019
crossref_primary_10_1155_2012_709531
crossref_primary_10_1080_17453670810016894
crossref_primary_10_1093_bja_ael066
crossref_primary_10_1046_j_1460_9592_2002_0787f_x
crossref_primary_10_1097_ACO_0b013e32830c214c
crossref_primary_10_1213_ANE_0b013e318206bc30
crossref_primary_10_1016_j_anchir_2005_11_015
crossref_primary_10_1007_s00228_018_2503_8
crossref_primary_10_1016_j_gyobfe_2011_07_035
crossref_primary_10_1371_journal_pone_0291793
crossref_primary_10_1053_jars_2001_19684
crossref_primary_10_1111_bcpt_13998
crossref_primary_10_1017_S0265021503210425
crossref_primary_10_1213_01_ANE_0000096008_24193_05
crossref_primary_10_1007_s00540_014_1864_0
crossref_primary_10_1097_00001503_199808000_00002
crossref_primary_10_1111_jog_12074
crossref_primary_10_1016_j_sjpain_2016_05_041
crossref_primary_10_1034_j_1399_6576_2000_00522_x
crossref_primary_10_1111_anae_13221
crossref_primary_10_1111_j_1460_9592_2011_03692_x
crossref_primary_10_17245_jdapm_2019_19_4_181
crossref_primary_10_1034_j_1399_6576_2001_045005652_x
crossref_primary_10_1186_s13018_024_05189_7
crossref_primary_10_2147_DDDT_S255385
crossref_primary_10_7759_cureus_48234
crossref_primary_10_1016_j_bpa_2019_07_017
crossref_primary_10_1007_s00268_015_2973_0
crossref_primary_10_1007_s00101_007_1230_9
crossref_primary_10_1016_j_bpa_2022_03_001
crossref_primary_10_1177_0310057X0503300508
crossref_primary_10_1007_s40266_019_00652_1
crossref_primary_10_1046_j_1460_9592_2000_00532_x
crossref_primary_10_3389_fphar_2025_1540606
crossref_primary_10_1213_01_ane_0000255706_11417_9b
crossref_primary_10_4103_0259_1162_200231
crossref_primary_10_1111_j_1399_6576_2007_01412_x
crossref_primary_10_1007_s00256_008_0567_8
crossref_primary_10_1213_ane_0b013e31816d12af
crossref_primary_10_1097_ACO_0b013e3281c10a08
crossref_primary_10_1016_j_gyobfe_2008_03_007
crossref_primary_10_1016_j_arth_2020_01_030
crossref_primary_10_1097_AAP_0000000000000834
crossref_primary_10_1097_BPO_0000000000002779
crossref_primary_10_1213_00000539_200302000_00048
crossref_primary_10_1016_j_bpa_2007_06_005
crossref_primary_10_1007_s00101_006_0981_z
crossref_primary_10_4103_cjhr_cjhr_118_23
crossref_primary_10_1097_00000539_200012000_00025
crossref_primary_10_4103_0019_5049_147163
crossref_primary_10_1007_s00101_010_1724_8
crossref_primary_10_1016_S0246_0335_02_00059_5
crossref_primary_10_1007_s40883_021_00223_0
crossref_primary_10_3109_17453674_2014_899840
crossref_primary_10_4103_0019_5049_79875
crossref_primary_10_1016_j_artd_2017_07_008
crossref_primary_10_1007_BF03190406
crossref_primary_10_1093_bja_aet412
crossref_primary_10_1111_j_1442_9071_2006_01409_x
crossref_primary_10_4103_0970_5333_124602
crossref_primary_10_1097_BRS_0000000000004249
crossref_primary_10_1111_j_1399_6576_2006_01259_x
crossref_primary_10_1111_j_1479_828X_2000_tb01176_x
crossref_primary_10_4103_0970_5333_124603
crossref_primary_10_1111_aas_13410
crossref_primary_10_1213_01_ane_0000287650_75027_11
crossref_primary_10_5435_JAAOSGlobal_D_21_00287
crossref_primary_10_1111_j_1399_6576_1997_tb04857_x
crossref_primary_10_1016_j_bja_2024_10_041
crossref_primary_10_1097_AAP_0000000000000727
crossref_primary_10_1111_j_1600_0420_2007_00976_x
crossref_primary_10_18410_jebmh_2020_308
crossref_primary_10_1213_00000539_199712000_00026
crossref_primary_10_12677_ACM_2022_12111568
crossref_primary_10_1007_s11605_017_3402_5
crossref_primary_10_1016_j_ijporl_2009_05_006
crossref_primary_10_1111_j_1460_9592_2004_01373_x
crossref_primary_10_1097_MD_0000000000015526
crossref_primary_10_1007_BF03018592
crossref_primary_10_1007_s00540_016_2193_2
crossref_primary_10_31083_j_ceog_2021_03_2476
crossref_primary_10_1046_j_1460_9592_2001_00742_x
crossref_primary_10_1053_j_otsm_2016_12_003
crossref_primary_10_2106_JBJS_16_00733
crossref_primary_10_1017_S0265021503000401
crossref_primary_10_1213_00000539_200008000_00032
crossref_primary_10_1054_ijoa_2000_0763
crossref_primary_10_1177_0310057X0203000311
crossref_primary_10_1097_00000539_200302000_00048
crossref_primary_10_17245_jdapm_2021_21_4_337
crossref_primary_10_1097_ALN_0b013e3182a66d4d
crossref_primary_10_2199_jjsca_32_331
crossref_primary_10_1097_MD_0000000000040707
crossref_primary_10_1080_10837450_2020_1871011
crossref_primary_10_1097_00003643_200303000_00004
crossref_primary_10_4097_kjae_2007_53_4_486
crossref_primary_10_1097_AAP_0000000000000816
crossref_primary_10_1034_j_1399_6576_2002_460526_1_x
crossref_primary_10_4103_ijo_IJO_100_18
crossref_primary_10_1213_ANE_0000000000004224
crossref_primary_10_1016_S0750_7658_02_00699_8
crossref_primary_10_1046_j_1365_2125_2003_01732_x
crossref_primary_10_1007_s11420_010_9155_2
crossref_primary_10_1093_bja_85_6_830
crossref_primary_10_1016_j_jclinane_2015_03_021
crossref_primary_10_2106_JBJS_G_01033
crossref_primary_10_1097_EJA_0000000000000345
crossref_primary_10_2165_00128415_199706540_00009
crossref_primary_10_1136_rapm_2021_102984
crossref_primary_10_4174_jkss_2010_79_2_130
crossref_primary_10_1093_bja_aeq365
crossref_primary_10_1097_01_sa_0000087702_31092_6b
crossref_primary_10_1097_00115550_200207000_00006
crossref_primary_10_4103_0019_5049_162988
crossref_primary_10_14260_jemds_2016_1153
crossref_primary_10_1067_moe_2002_121390
crossref_primary_10_1111_j_1445_2197_2011_05754_x
crossref_primary_10_1016_S0378_4347_98_00018_8
crossref_primary_10_1007_s00414_018_1858_9
crossref_primary_10_1007_s00540_007_0518_x
crossref_primary_10_1097_00000539_200012000_00033
crossref_primary_10_1111_aas_12849
crossref_primary_10_1111_j_1526_4637_2008_00418_x
crossref_primary_10_1016_j_annfar_2008_03_008
crossref_primary_10_1097_00000539_200101000_00039
crossref_primary_10_1017_S0265021503000413
crossref_primary_10_1007_s40122_013_0021_z
crossref_primary_10_1038_s41598_020_59370_z
crossref_primary_10_1111_j_1365_2508_2002_00559_x
crossref_primary_10_1155_2012_458795
crossref_primary_10_1517_17425255_2010_514265
crossref_primary_10_1093_bja_aep285
crossref_primary_10_1097_AAP_0b013e31823d0a80
crossref_primary_10_1517_17425241003767383
crossref_primary_10_1093_bja_aeq255
crossref_primary_10_1177_147323001003800422
crossref_primary_10_1016_j_arth_2017_07_038
crossref_primary_10_1053_j_jvca_2024_06_006
crossref_primary_10_1016_j_tacc_2012_11_002
crossref_primary_10_1097_00000539_200107000_00037
crossref_primary_10_1111_j_1460_9592_2005_01778_x
crossref_primary_10_1038_s41598_022_26557_5
crossref_primary_10_1093_bja_87_1_27
crossref_primary_10_4103_0970_9185_81842
crossref_primary_10_1213_01_ANE_0000075839_18073_37
crossref_primary_10_14260_Jemds_2017_748
crossref_primary_10_1097_00003643_200310000_00009
crossref_primary_10_1007_s10049_013_1687_9
crossref_primary_10_1186_s12871_015_0084_y
crossref_primary_10_1016_j_jclinane_2013_07_013
crossref_primary_10_1093_asjof_ojab047
crossref_primary_10_1111_anae_12559
crossref_primary_10_1097_AIA_0b013e31823bc2eb
crossref_primary_10_1007_s00101_007_1147_3
crossref_primary_10_1007_s00540_017_2307_5
crossref_primary_10_1016_j_bjan_2019_12_006
crossref_primary_10_1097_EJA_0000000000000564
crossref_primary_10_1017_S0265021503000310
crossref_primary_10_1111_j_1440_1681_2009_05163_x
crossref_primary_10_1034_j_1399_6576_2003_00146_x
crossref_primary_10_1007_s40263_022_00936_y
crossref_primary_10_1034_j_1399_6576_2000_440415_x
crossref_primary_10_18410_jebmh_2016_589
crossref_primary_10_1016_j_bjae_2019_03_001
crossref_primary_10_1016_j_otsr_2017_10_004
crossref_primary_10_1111_j_1399_6576_2007_01421_x
crossref_primary_10_4103_2349_0977_168252
crossref_primary_10_1016_j_anclin_2019_08_002
crossref_primary_10_1016_j_otsr_2015_09_006
crossref_primary_10_1213_ANE_0000000000005225
crossref_primary_10_1016_j_clinthera_2024_11_003
crossref_primary_10_1007_BF03019882
crossref_primary_10_1213_00000539_199909000_00037
crossref_primary_10_1016_j_aan_2018_07_008
crossref_primary_10_1007_s00142_016_0072_3
crossref_primary_10_1213_00000539_199909000_00032
crossref_primary_10_4103_0259_1162_154541
crossref_primary_10_1186_s12891_024_07261_z
crossref_primary_10_5397_cise_2021_00332
crossref_primary_10_1016_j_ijoa_2005_09_010
crossref_primary_10_1016_j_jiec_2019_02_028
crossref_primary_10_1093_bja_aep023
crossref_primary_10_1097_MJT_0000000000001132
crossref_primary_10_1017_S0265021503000322
crossref_primary_10_1097_00000539_199909000_00037
crossref_primary_10_1016_S0950_3552_98_80078_3
crossref_primary_10_1016_S1279_7960_04_98247_2
crossref_primary_10_1053_j_jvca_2007_06_005
crossref_primary_10_1007_s12630_022_02260_x
crossref_primary_10_1016_j_accpm_2018_08_002
crossref_primary_10_1007_s00423_010_0735_x
crossref_primary_10_1097_00000539_199909000_00032
crossref_primary_10_1016_j_bpa_2019_07_005
crossref_primary_10_3390_biomedicines12102303
crossref_primary_10_1016_j_ejphar_2010_08_014
crossref_primary_10_1093_bja_aeh066
crossref_primary_10_1213_01_ane_0000194590_82645_4c
crossref_primary_10_1136_rapm_2022_104166
crossref_primary_10_1213_ANE_0000000000006282
crossref_primary_10_1017_S0265021503000334
crossref_primary_10_1007_s12013_014_9851_5
crossref_primary_10_1097_00000539_200103000_00032
crossref_primary_10_4236_ojanes_2014_48025
crossref_primary_10_1093_bja_aeu363
crossref_primary_10_2165_00002018_200427140_00003
crossref_primary_10_1111_j_1399_6576_2007_01443_x
crossref_primary_10_2165_00044011_200323040_00004
crossref_primary_10_5435_JAAOS_D_22_01179
crossref_primary_10_1097_ACO_0000000000000091
crossref_primary_10_1034_j_1399_6576_2003_470117_x
crossref_primary_10_1177_147323000703500304
crossref_primary_10_1016_j_vascn_2017_10_002
crossref_primary_10_1007_s00167_020_05981_y
crossref_primary_10_1097_AAP_0000000000000349
crossref_primary_10_1017_S0265021503230428
crossref_primary_10_1007_BF03018891
crossref_primary_10_3390_ijms252413487
crossref_primary_10_1016_j_annfar_2005_08_002
crossref_primary_10_1053_trap_2001_24357
crossref_primary_10_1097_AAP_0b013e31824c20a9
crossref_primary_10_1017_S0265021503000346
crossref_primary_10_1345_aph_10200
crossref_primary_10_1007_s11701_011_0276_5
crossref_primary_10_1186_s12871_024_02816_y
crossref_primary_10_1097_EJA_0000000000000317
crossref_primary_10_1111_j_1399_6576_1998_tb05347_x
crossref_primary_10_3928_01477447_20110714_11
crossref_primary_10_4055_jkoa_2023_58_2_133
crossref_primary_10_1007_s00266_006_0187_4
crossref_primary_10_1097_01_ana_0000171730_41008_da
crossref_primary_10_1089_wound_2023_0059
crossref_primary_10_1177_201010581302200205
crossref_primary_10_1007_s00404_022_06880_y
crossref_primary_10_1097_DCR_0000000000001464
crossref_primary_10_1111_j_1365_2044_2010_06454_x
crossref_primary_10_1213_00000539_199912000_00027
crossref_primary_10_17816_1993_6508_2020_14_3_149_155
crossref_primary_10_2165_00003088_200443010_00002
crossref_primary_10_4097_kja_d_18_00290
crossref_primary_10_1111_j_1460_9592_2009_03009_x
crossref_primary_10_22141_2224_0586_17_4_2021_237728
crossref_primary_10_1007_s00540_016_2201_6
crossref_primary_10_1111_pan_12899
crossref_primary_10_1093_bja_aei135
crossref_primary_10_1016_j_annfar_2009_01_007
crossref_primary_10_1007_s00167_012_2202_4
crossref_primary_10_1097_00000539_199912000_00027
crossref_primary_10_1007_BF03017795
crossref_primary_10_1016_S1762_827X_19_42990_8
crossref_primary_10_1097_EJA_0000000000000762
crossref_primary_10_1093_bja_aet015
crossref_primary_10_1093_bja_aeh051
crossref_primary_10_1016_j_annfar_2010_05_033
crossref_primary_10_1097_00115550_200601000_00006
crossref_primary_10_1213_01_ANE_0000090320_46129_BE
crossref_primary_10_1213_ANE_0b013e3181f3fb19
crossref_primary_10_1155_2020_5982567
crossref_primary_10_1097_00000539_200201000_00019
crossref_primary_10_1111_j_1365_2044_2012_07314_x
crossref_primary_10_1093_bja_aes286
crossref_primary_10_1213_ANE_0000000000000768
crossref_primary_10_1213_ANE_0000000000000646
crossref_primary_10_1016_j_annfar_2012_01_018
crossref_primary_10_1213_00000539_200201000_00019
crossref_primary_10_1054_ijoa_2001_0859
crossref_primary_10_1097_00000539_199712000_00026
crossref_primary_10_1046_j_1365_2044_2001_01908_x
crossref_primary_10_1186_s12891_018_2154_z
crossref_primary_10_1213_ANE_0b013e3181e3a08e
crossref_primary_10_4103_0019_5049_151378
crossref_primary_10_1007_s00540_011_1125_4
crossref_primary_10_1097_01_sap_0000171427_86614_57
crossref_primary_10_1017_S0265021503220421
crossref_primary_10_1034_j_1399_6576_2002_460524_x
crossref_primary_10_3109_17453674_2010_487241
crossref_primary_10_1111_j_1460_9592_2011_03771_x
crossref_primary_10_1017_S0265021503000358
crossref_primary_10_1097_AAP_0b013e3181c9662c
crossref_primary_10_1111_j_1399_6576_1998_tb05346_x
crossref_primary_10_1136_bjophthalmol_2016_309780
crossref_primary_10_1016_j_ijoa_2006_07_008
crossref_primary_10_1016_S0039_6109_05_70386_8
crossref_primary_10_1097_01_ana_0000167446_56839_a4
crossref_primary_10_1007_s00194_012_0861_6
crossref_primary_10_1097_00115550_200507000_00008
crossref_primary_10_1097_AAP_0000000000000415
crossref_primary_10_1213_01_ANE_0000093310_47375_44
crossref_primary_10_2165_00023210_200620110_00005
crossref_primary_10_1111_pan_12438
crossref_primary_10_1007_s00540_016_2248_4
crossref_primary_10_1017_S0265021503001339
crossref_primary_10_1016_j_bja_2017_12_040
crossref_primary_10_1016_j_bjane_2018_01_008
crossref_primary_10_1016_j_anrea_2017_01_013
crossref_primary_10_1016_S0750_7658_02_00781_5
crossref_primary_10_1017_S026502150300036X
crossref_primary_10_1097_00115550_200211000_00012
crossref_primary_10_1136_bmjopen_2014_005823
crossref_primary_10_1093_bja_89_5_707
crossref_primary_10_1016_j_jor_2015_05_012
crossref_primary_10_1017_S0265021503000371
crossref_primary_10_1097_AAP_0000000000000543
crossref_primary_10_1097_00115550_200211000_00010
crossref_primary_10_1097_00000539_200001000_00028
crossref_primary_10_1007_s12630_010_9275_7
crossref_primary_10_1016_j_jchromb_2023_123716
crossref_primary_10_1016_j_recote_2015_03_009
crossref_primary_10_1016_S0246_0289_10_44745_3
crossref_primary_10_1093_bja_aeg064
crossref_primary_10_1136_rapm_2022_104252
crossref_primary_10_1016_S1283_081X_02_71905_X
crossref_primary_10_1093_bja_87_5_784
crossref_primary_10_1111_anae_13375
crossref_primary_10_1111_j_1556_4029_2011_01829_x
crossref_primary_10_1186_s12871_021_01295_9
crossref_primary_10_1017_S0265021503240424
crossref_primary_10_1097_ACO_0000000000001398
crossref_primary_10_1213_ANE_0b013e3181c76a33
crossref_primary_10_1017_S0265021503000383
crossref_primary_10_1053_trap_2003_123518
crossref_primary_10_1111_anae_13017
crossref_primary_10_1016_S1283_0771_10_70257_7
crossref_primary_10_1097_00000539_200205000_00052
crossref_primary_10_1097_00003643_200706001_00374
crossref_primary_10_1016_j_jddst_2020_101810
crossref_primary_10_1017_S0265021506000263
crossref_primary_10_23736_S0375_9393_24_17927_8
crossref_primary_10_1007_s40261_017_0495_2
crossref_primary_10_1097_AAP_0b013e318240957f
crossref_primary_10_1186_s40634_023_00591_2
crossref_primary_10_1093_bja_aeg277
crossref_primary_10_1046_j_1524_4725_1999_99087_x
crossref_primary_10_1111_j_1533_2500_2012_00595_x
crossref_primary_10_1177_1758573220916916
crossref_primary_10_1097_SLA_0b013e318221f0cf
crossref_primary_10_3389_fmed_2024_1465308
crossref_primary_10_1163_1568569054729481
crossref_primary_10_1016_j_advms_2019_12_006
crossref_primary_10_1016_j_bja_2020_11_038
crossref_primary_10_1097_AIA_0b013e31821b7bf7
crossref_primary_10_1136_rapm_2023_104667
crossref_primary_10_1177_0091270011419853
crossref_primary_10_1213_ANE_0b013e3182288deb
crossref_primary_10_1016_j_jse_2023_05_009
crossref_primary_10_1016_j_jcms_2019_07_019
crossref_primary_10_1097_EJA_0000000000000963
crossref_primary_10_4103_0189_6725_62860
crossref_primary_10_1136_rapm_2023_104666
crossref_primary_10_1213_XAA_0000000000000477
crossref_primary_10_1017_S0265021503000395
crossref_primary_10_1093_bja_aer154
crossref_primary_10_1111_j_1399_6576_2009_02200_x
crossref_primary_10_1053_j_jvca_2010_08_009
crossref_primary_10_1034_j_1399_6576_2000_440911_x
crossref_primary_10_5863_1551_6776_26_5_445
crossref_primary_10_1016_j_knee_2014_04_008
crossref_primary_10_1080_22201173_2009_10872619
crossref_primary_10_3341_jkos_2021_62_12_1600
crossref_primary_10_1016_j_jclinane_2013_11_008
crossref_primary_10_1136_rapm_2022_104110
crossref_primary_10_1163_1568569053749994
crossref_primary_10_3390_jcm12247720
crossref_primary_10_1016_S0889_8537_05_70168_1
crossref_primary_10_1016_j_tetlet_2008_06_028
crossref_primary_10_1111_anae_13234
crossref_primary_10_1136_rapm_2020_102254
crossref_primary_10_1007_s12630_012_9685_9
crossref_primary_10_1093_bja_85_4_506
crossref_primary_10_2199_jjsca_29_724
crossref_primary_10_36106_ijar_9414114
crossref_primary_10_1016_j_bja_2022_08_030
crossref_primary_10_1213_01_ane_0000229652_70488_32
crossref_primary_10_1016_j_rcot_2015_09_288
crossref_primary_10_4111_kju_2007_48_2_163
crossref_primary_10_1213_00000539_199905000_00033
crossref_primary_10_1097_01_sap_0000151460_74629_b2
crossref_primary_10_1007_BF03016528
crossref_primary_10_2165_00003495_200565180_00013
crossref_primary_10_1002_cpdd_452
crossref_primary_10_1034_j_1399_6576_2001_450808_x
crossref_primary_10_1053_trap_2001_23679
crossref_primary_10_1111_j_1460_9592_2000_00578_x
crossref_primary_10_1007_s00540_016_2230_1
crossref_primary_10_4097_kjae_2007_53_6_746
crossref_primary_10_1007_s00540_011_1107_6
crossref_primary_10_1097_ACO_0000000000000254
crossref_primary_10_1177_0310057X1003800404
crossref_primary_10_1213_00000539_200202000_00006
crossref_primary_10_1097_EJA_0000000000000943
crossref_primary_10_2152_jmi_66_303
crossref_primary_10_4103_joacp_JOACP_341_18
crossref_primary_10_1097_00000539_200202000_00042
crossref_primary_10_1136_bcr_2016_215071
crossref_primary_10_1111_jog_12999
crossref_primary_10_1016_j_bjane_2019_12_001
crossref_primary_10_1007_s00402_008_0770_z
crossref_primary_10_1111_j_1365_2125_2012_04470_x
crossref_primary_10_1213_ANE_0000000000001200
crossref_primary_10_1016_j_recot_2014_11_005
crossref_primary_10_1007_BF03013129
crossref_primary_10_1213_00000539_200011000_00030
crossref_primary_10_1111_1440_1681_12730
crossref_primary_10_1093_bja_ael281
crossref_primary_10_1007_s00540_014_1815_9
crossref_primary_10_1034_j_1399_6576_2001_451017_x
crossref_primary_10_1111_j_1399_6576_2010_02332_x
crossref_primary_10_1016_j_eujps_2011_08_003
crossref_primary_10_1093_bja_aex005
crossref_primary_10_1213_ANE_0000000000001329
crossref_primary_10_2344_0003_3006_2006_53_3_AEODRC_2_0_CO_2
crossref_primary_10_2199_jjsca_29_509
crossref_primary_10_1007_BF03026796
crossref_primary_10_1111_ans_18257
crossref_primary_10_1111_j_1460_9592_2005_01715_x
crossref_primary_10_1016_S1283_0771_19_41578_8
crossref_primary_10_4097_kjae_2015_68_1_50
crossref_primary_10_2106_00004623_200605000_00005
crossref_primary_10_3390_jcm11216384
crossref_primary_10_1213_ANE_0000000000000364
crossref_primary_10_1213_01_ANE_0000069506_68137_F2
crossref_primary_10_1213_01_ane_0000286176_55971_f0
crossref_primary_10_1111_pan_14556
crossref_primary_10_1007_s00167_011_1841_1
crossref_primary_10_1093_bja_ael249
crossref_primary_10_1007_s00210_016_1231_9
crossref_primary_10_1016_j_ejpb_2008_11_003
crossref_primary_10_1016_S0966_6532_98_00029_8
crossref_primary_10_1213_01_ANE_0000157123_69327_6A
crossref_primary_10_1046_j_1467_2995_2001_00025_x
crossref_primary_10_1007_s12070_020_02309_7
crossref_primary_10_1002_pne2_12126
crossref_primary_10_1155_2019_1412737
crossref_primary_10_2106_JBJS_E_00344
crossref_primary_10_1213_ANE_0000000000001217
crossref_primary_10_1097_AAP_0000000000000288
crossref_primary_10_2199_jjsca_29_519
crossref_primary_10_3349_ymj_2014_55_2_517
crossref_primary_10_2147_LRA_S425353
crossref_primary_10_1053_trap_2001_23682
crossref_primary_10_2165_00003495_200161030_00002
crossref_primary_10_1213_01_ANE_0000130260_24433_A2
crossref_primary_10_1016_S0952_8180_02_00451_8
crossref_primary_10_1016_j_jclinane_2004_07_009
crossref_primary_10_7759_cureus_67565
crossref_primary_10_1016_j_sagf_2012_02_002
crossref_primary_10_1093_bja_ael145
crossref_primary_10_1213_00000539_200103000_00032
crossref_primary_10_1017_S0265021507003146
crossref_primary_10_1053_j_jvca_2020_12_011
crossref_primary_10_1007_s00101_022_01118_7
crossref_primary_10_1007_BF03018916
crossref_primary_10_1213_ANE_0000000000000019
crossref_primary_10_1016_j_bpa_2004_12_003
crossref_primary_10_1016_j_bja_2018_09_024
crossref_primary_10_1016_j_janh_2018_10_007
crossref_primary_10_1053_j_trap_2013_08_004
crossref_primary_10_12923_2083_4829_2024_0017
crossref_primary_10_1016_j_bpa_2011_06_002
crossref_primary_10_1016_j_jpedsurg_2004_05_002
crossref_primary_10_1111_j_1460_9592_2004_01443_x
crossref_primary_10_1007_BF03016846
crossref_primary_10_1016_S1280_4703_10_70431_X
crossref_primary_10_1016_j_jclinane_2007_03_006
crossref_primary_10_1213_00000539_200202000_00042
crossref_primary_10_1016_j_jclinane_2008_05_016
crossref_primary_10_1034_j_1399_6576_2001_045004489_x
crossref_primary_10_14260_jemds_2015_2081
crossref_primary_10_1097_00000539_200011000_00030
crossref_primary_10_1097_00000539_200202000_00006
crossref_primary_10_1097_ALN_0000000000001230
crossref_primary_10_1093_bja_85_3_347
crossref_primary_10_1177_0310057X1003800205
crossref_primary_10_17085_apm_21093
crossref_primary_10_1097_00000539_199905000_00033
crossref_primary_10_1093_bja_87_4_570
crossref_primary_10_4103_joacp_joacp_353_22
crossref_primary_10_1016_j_arth_2008_05_001
crossref_primary_10_1007_s43465_024_01298_x
crossref_primary_10_1177_0310057X0603400617
crossref_primary_10_1111_j_1365_2044_2012_07056_x
crossref_primary_10_1097_00003643_200403000_00016
crossref_primary_10_1136_rapm_2022_103683
crossref_primary_10_1111_j_1399_6576_2004_00580_x
crossref_primary_10_1097_00001503_200310000_00004
crossref_primary_10_1016_j_accpm_2015_08_002
crossref_primary_10_1097_ANA_0000000000000149
crossref_primary_10_1007_s00534_010_0271_7
crossref_primary_10_1016_j_egja_2011_06_007
crossref_primary_10_1016_j_jclinane_2016_08_020
crossref_primary_10_1017_S0265021503250420
crossref_primary_10_1007_s00167_013_2566_0
crossref_primary_10_1111_j_1742_7843_2006_pto_397_x
crossref_primary_10_1007_s00464_014_3671_y
crossref_primary_10_1080_02844310500475784
crossref_primary_10_1080_14740338_2019_1617271
crossref_primary_10_1016_j_jclinane_2008_10_011
crossref_primary_10_4097_kjae_2017_70_2_120
crossref_primary_10_1111_anae_14178
crossref_primary_10_1093_bja_88_4_563
crossref_primary_10_1016_j_ijporl_2007_11_011
crossref_primary_10_1097_ALN_0b013e31828ce74d
crossref_primary_10_1007_s12325_020_01565_x
crossref_primary_10_1016_j_ijoa_2024_103975
crossref_primary_10_1046_j_1460_9592_2001_00691_x
crossref_primary_10_1046_j_1460_9592_2002_00769_x
crossref_primary_10_1186_s12871_018_0512_x
crossref_primary_10_1016_j_jclinane_2016_08_025
crossref_primary_10_1213_ANE_0000000000003837
crossref_primary_10_4103_0019_5049_93339
crossref_primary_10_1016_j_bja_2022_05_013
crossref_primary_10_1111_1742_6723_12539
crossref_primary_10_3344_kjp_2021_34_2_193
crossref_primary_10_1016_j_jmig_2009_04_002
crossref_primary_10_1034_j_1600_0773_2002_900401_x
crossref_primary_10_12771_emj_2017_40_4_164
crossref_primary_10_4103_2045_9912_359678
crossref_primary_10_1007_s40140_016_0144_y
crossref_primary_10_1016_j_jclinane_2008_10_006
crossref_primary_10_1053_j_jepm_2011_07_010
crossref_primary_10_1016_S1130_6343_07_75725_2
crossref_primary_10_1155_2018_9150980
crossref_primary_10_1097_PRS_0000000000011485
crossref_primary_10_4097_kjae_2012_63_3_227
crossref_primary_10_1007_s12663_016_0902_x
crossref_primary_10_1016_j_bpa_2004_11_001
crossref_primary_10_1111_j_1365_2044_2010_06449_x
crossref_primary_10_1016_j_annfar_2006_10_016
crossref_primary_10_1016_j_ijoa_2010_03_002
crossref_primary_10_1097_SCS_0b013e31848432e4
crossref_primary_10_1213_01_ane_0000185038_86939_74
crossref_primary_10_1016_S0277_0326_00_80025_2
crossref_primary_10_3113_FAI_2011_0856
crossref_primary_10_1016_j_medpal_2020_01_005
crossref_primary_10_1016_j_jse_2018_09_026
crossref_primary_10_1007_BF03012217
crossref_primary_10_1093_bja_aet065
crossref_primary_10_1097_00115550_200511000_00008
crossref_primary_10_3390_pharmaceutics17030386
crossref_primary_10_1002_jcp_28407
crossref_primary_10_1097_00115550_200511000_00009
ContentType Journal Article
Copyright 1997 British Journal of Anaesthesia
1997 INIST-CNRS
Copyright British Medical Association May 1997
Copyright_xml – notice: 1997 British Journal of Anaesthesia
– notice: 1997 INIST-CNRS
– notice: Copyright British Medical Association May 1997
DBID 6I.
AAFTH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1093/bja/78.5.507
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1471-6771
EndPage 514
ExternalDocumentID 14413726
9175963
2681706
10_1093_bja_78_5_507
10.1093/bja/78.5.507
S0007091217399695
Genre Comparative Study
Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-E4
.2P
.55
.GJ
.I3
.XZ
.ZR
18M
1TH
23N
2WC
354
3O-
4.4
482
48X
53G
5GY
5RE
5VS
5WA
6.Y
6I.
6PF
70D
AACTN
AAEDW
AAESY
AAFTH
AAIAV
AAIYJ
AAJKP
AALRI
AAMVS
AAOGV
AAPNW
AAPXW
AAQQT
AAUQX
AAVAP
AAWTL
AAXUO
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABMAC
ABNKS
ABPTD
ABQLI
ABQTQ
ABSMQ
ABVKL
ABXVV
ABZBJ
ACCJX
ACFRR
ACGFO
ACGFS
ACMRT
ACPQN
ACUFI
ACUTJ
ACUTO
ADBBV
ADEYI
ADHKW
ADHZD
ADJQC
ADOCK
ADORX
ADQLU
ADRIX
ADZXQ
AEGPL
AEJOX
AEKPW
AEMDU
AENEX
AENZO
AEPUE
AEWNT
AFFNX
AFIYH
AFOSN
AFTJW
AFXEN
AGKEF
AGKRT
AGSYK
AHMBA
AHPSJ
AHXPO
AI.
AIAGR
AIJHB
AITUG
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMRAJ
APIBT
APWMN
ASPBG
AVWKF
AWCFO
AXUDD
AZFZN
BAWUL
BEYMZ
BGYMP
BHONS
BVRKM
BZKNY
C1A
C45
CAG
COF
CS3
CZ4
DIK
DILTD
DU5
D~K
E3Z
EBS
EE~
EJD
F5P
F9B
FDB
FEDTE
GX1
H5~
HAR
HVGLF
HW0
HZ~
IH2
IOX
J21
J5H
KAQDR
KC5
KOP
KQ8
KSI
KSN
L7B
M-Z
M41
M49
N9A
NCXOZ
NGC
NTWIH
NU-
O0~
OAWHX
OHH
OJQWA
OJZSN
OK1
OVD
O~Y
P2P
PB-
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
RHF
RNI
ROL
ROX
ROZ
RW1
RXO
RZF
RZO
SSZ
TEORI
TJX
TMA
TR2
VH1
W2D
W8F
WH7
WOQ
WOW
X7H
X7M
YHG
ZA5
ZGI
ZKX
ZXP
~91
0R~
0SF
ADVLN
AFETI
AFSHK
AGMDO
AKRWK
H13
AAFWJ
AAYWO
AAYXX
ABEJV
ABGNP
ABNGD
ACUKT
ACVCV
ACVFH
ADCNI
AEHUL
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AIGII
AKBMS
AKYEP
APJGH
APXCP
CITATION
P0W
EFKBS
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
ID FETCH-LOGICAL-c487t-b0d8d567f088f7a28fb8d9d0051c89d675aadccbd7f941b6ede8b137059b971c3
ISSN 0007-0912
IngestDate Fri Jul 11 02:02:10 EDT 2025
Sun Jul 13 04:59:50 EDT 2025
Wed Feb 19 02:32:24 EST 2025
Mon Jul 21 09:14:35 EDT 2025
Thu Apr 24 23:01:07 EDT 2025
Tue Jul 01 02:00:51 EDT 2025
Wed Sep 11 04:47:55 EDT 2024
Fri Feb 23 02:22:48 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Human
Nervous system diseases
Echocardiography
Intravenous administration
Toxicity
Cardiovascular disease
Ropivacaine
Local anesthetic
Bupivacaine
Activity concentration relation
Central nervous system disease
Electrocardiography
Hemodynamics
Anilide
Comparative study
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
https://www.elsevier.com/open-access/userlicense/1.0
CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c487t-b0d8d567f088f7a28fb8d9d0051c89d675aadccbd7f941b6ede8b137059b971c3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://dx.doi.org/10.1093/bja/78.5.507
PMID 9175963
PQID 197863861
PQPubID 41750
PageCount 8
ParticipantIDs proquest_miscellaneous_79050549
proquest_journals_197863861
pubmed_primary_9175963
pascalfrancis_primary_2681706
crossref_citationtrail_10_1093_bja_78_5_507
crossref_primary_10_1093_bja_78_5_507
oup_primary_10_1093_bja_78_5_507
elsevier_sciencedirect_doi_10_1093_bja_78_5_507
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1997-05-01
PublicationDateYYYYMMDD 1997-05-01
PublicationDate_xml – month: 05
  year: 1997
  text: 1997-05-01
  day: 01
PublicationDecade 1990
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
– name: London
PublicationTitle British journal of anaesthesia : BJA
PublicationTitleAbbrev Br J Anaesth
PublicationTitleAlternate Br J Anaesth
PublicationYear 1997
Publisher Elsevier Ltd
Oxford University Press
Oxford Publishing Limited (England)
Publisher_xml – name: Elsevier Ltd
– name: Oxford University Press
– name: Oxford Publishing Limited (England)
SSID ssj0017295
Score 2.1507907
Snippet We have compared the incidence of CNS symptoms and changes in echocardiography and electrophysiology during i.v. infusions of ropivacaine, bupivacaine and...
SourceID proquest
pubmed
pascalfrancis
crossref
oup
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 507
SubjectTerms Adult
Amides - adverse effects
Amides - blood
Amides - pharmacology
Anesthetics, Local - adverse effects
Anesthetics, Local - blood
Anesthetics, Local - pharmacology
Biological and medical sciences
Bupivacaine - adverse effects
Bupivacaine - blood
Bupivacaine - pharmacology
Central Nervous System Diseases - chemically induced
Cross-Over Studies
Double-Blind Method
Drug Administration Schedule
Drug toxicity and drugs side effects treatment
Electrocardiography - drug effects
Hemodynamics - drug effects
Humans
Infusions, Intravenous
Male
Medical sciences
Pharmacology. Drug treatments
Ropivacaine
Toxicity: nervous system and muscle
Ventricular Function, Left - drug effects
Title Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers
URI https://dx.doi.org/10.1093/bja/78.5.507
https://www.ncbi.nlm.nih.gov/pubmed/9175963
https://www.proquest.com/docview/197863861
https://www.proquest.com/docview/79050549
Volume 78
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKeEFCCAQTZQz8AE8jbfNlJ490YpqYQEJs0t4iO05Ety6p2mYP_AR-Ncex8wVUA16i1rGtKOfk-t7re68JeQOl3M89P3DYLPOcQLHAkTDgnIz5yhN8FuVCZyN_-sxOL4KPl-HlaPSjF7VUbeUk_f7HvJL_QRVtwFVnyf4Dsu2kaMBv4IsrEMb1rzC2rtmjAh-8DmWtc9SGAaa9eI3F5Haig6-qTRP8ti5Xi1uRioVxa8qq_WvqB2gXuyy1S0QLMUBgw-V_rYjUKz8hCoF15lu2WYja2zDvKHJWVMr6e1rf6jxLr_UuwteqWl_rTfv58VIMnLTzZXnTxKB1R4Zd1X0ZXuay29tSNpuPd6GCrUBGW-wOBDKPesQLe9I1NAfk2oU6NNmnv60Bpj6WvMLTnvBoEk7aYYO62ru63iP3PZgcWmaefel2pGCEmNMw7APbJArMMMX4aTN6l3pjsicfroC-WObmzJTdRk2t3Jw_Jo-sVULfG4o9IaOseErWll7U0ouCE3RIL2rpRcucanrRll66pUevd7RHrnoiSy6MoB25npGLkw_nx6eOPaLDSWHpbh05U5EKGc-xWOVceFEuIxUrLerTKFawRoVQaSoVz-PAlSxTWSRdn0OplzF3U3-f7BVlkT0nVGI1UNCV0hQW_CwAWyRnmJ5JBWEyy8bkqHmzSWrr1-tjVJaJiaPwE-CQ8CgJE-AwJm_b3itTt2VHv2kDUmJ1TqNLJqDTjhEUWN4x6eEA6Lazx3Q9TDYmBw3wif1CN4kb8wiLIXPH5HV7F7Jeb-CJIgPMiS6mBxMrHpN9w5Z24hhWAJbSF3c_2wF50H2IL8nedl1lh9Crt_JVTfifL5rNBA
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Central+nervous+and+cardiovascular+effects+of+i.v.+infusions+of+ropivacaine%2C+bupivacaine+and+placebo+in+volunteers&rft.jtitle=British+journal+of+anaesthesia+%3A+BJA&rft.au=Knudsen%2C+K&rft.au=Beckman+Suurk%C3%BCla%2C+M&rft.au=Blomberg%2C+S&rft.au=Sj%C3%B6vall%2C+J&rft.date=1997-05-01&rft.issn=0007-0912&rft.volume=78&rft.issue=5&rft.spage=507&rft.epage=514&rft_id=info:doi/10.1093%2Fbja%2F78.5.507&rft.externalDocID=10.1093%2Fbja%2F78.5.507
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-0912&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-0912&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-0912&client=summon